Aaron Gerds, MD, MS; Cleveland Clinic; 5Live #ASH21
6:51
Key insights from the 2021 Annual Hematology meeting in Atlanta
Myeloproliferative Neoplasm
Aaron Gerds, MD, MS; Cleveland Clinic; 5Live #ASH21
Key insights from the 2021 Annual Hematology meeting in Atlanta
Myeloproliferative Neoplasm Similar Videos
Similar Videos
-
Treatment Selection and Emerging Therapeutic Options in JAK-Inhibitor Refractory/ Intolerant Myelofibrosis_Srdan Verstovsek, MD, PhD
16:54
-
Therapeutic Options for Patients with JAK-Inhibitor–Naïve Myelofibrosis_Naveen Pemmaraju, MD
21:38
-
Later Phase Trials for MPNs, CML and Systemic Mastocytosis_Mark Heaney, MD, PhD; #hemeupdates2022
16:20
